HOME >> BIOLOGY >> NEWS
Atmospheric chemistry key to global and local air pollution

Albuquerque, N.M. -- The chemical cycles in the troposphere along with pollutants of human and natural origin can alter the composition of the air and effect local, regional and global environmental quality, according to a Penn State researcher.

The troposphere -- the area of the Earth's atmosphere from the surface to ten miles above the surface where weather exists -- is also where pollution becomes a problem. In the atmosphere, a complex series of chemical reactions can alter some pollutants so that they rain out as aerosol particles or acid rain and clear the air. Other compounds remain in the air, changing, and changing again as other chemicals cause reactions.

"Pollution from megacities and biomass burning, including precursor gases to hydrogen oxides such as acetone and formaldehyde, lofted into the upper troposphere, can become the dominant hydrogen oxide source and result in efficient ozone production," says Dr. William Brune, professor of meteorology and head of Penn State's meteorology department. "These compounds can also be transported great distances before descent, possibly influencing the chemistry of remote regions."

Ozone is complicated. In the stratosphere it serves to protect life from the detrimental effects of the sun's ultraviolet radiation. At ground level, it is a pollutant implicated in respiratory problems and eye irritation. Sunlight breaks ozone apart resulting in the creation of the very reactive hydroxyl radical which begins the process that removes some pollutants from the air. However, when hydroxyl radicals break down some compounds, they produce other hydrogen oxides, which react with other pollutants and form ozone.

"The hydroxyl radical drives atmospheric oxidation by reacting with chemicals emitted from Earths surface, thus creating new chemicals that are more easily scavenged and removed by aerosols, clouds and rain," Brune told attendees today (Jan. 15) at the annual meeting of the American Meteorological Socie
'"/>

Contact: A'ndrea Elyse Messer
aem1@psu.edu
814-865-9481
Penn State
14-Jan-2001


Page: 1 2 3

Related biology news :

1. Atmospheric aerosols impact on smog formation being reassessed
2. Atmospheric carbon monoxide levels decreasing in mid-Atlantic region
3. 14,000 Years Of Atmospheric Lead Emissions Recorded In Swiss Peat Bog As Published In Science Magazine
4. Atmospheric Chemistry -- A Mysterious Isotope Effect In A Well-Known AtmosphericPollutant Discovered
5. U of T research answers key question in biochemistry
6. Carnegie Mellon University hosts ACS-PRF summer school on green chemistry
7. High profile publications in biology and biochemistry on rise at UH
8. Alcoholism risk linked to gene involved in brain chemistry
9. Biochemistry and Molecular Biology: Research at the Interface of Biochemistry and Human Health
10. Houston scientist named as rising star in chemistry
11. The American Society for Biochemistry and Molecular Biology meets in Boston

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Atmospheric chemistry key global and local air pollution

(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ... "Global Iris Recognition Market 2015-2019" report to ... Iris Recognition market to grow at a CAGR of ... report covers the present scenario and the growth prospects ... 2015-2019. To calculate the market size, the report considers ...
(Date:3/24/2015)... Fla. , March 24, 2015   ... management solutions, today announced that its U.are.U ® ... accessory retailer Goorin Bros . to achieve ... biometrics-based solution secures access to the POS terminal, ... increased risk of data breaches. ...
(Date:3/23/2015)... , March 23, 2015  In the 2014 fiscal ... case conviction losses. This figure accounts for a fraction ... to The Nilson Report, exceeds $11 billion globally. The ... after a crime has occurred. Investor Mark Saint ... expert Joe Paolella partnered to administer the ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
(Date:3/30/2015)... -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), a ... of innovative therapeutics addressing cancer and other unmet medical ... on China , announced today that ... the Company,s application to conduct a Phase 2 global ... for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... 30, 2015    Intrexon Corporation (NYSE: ... and Merck Serono, the biopharmaceutical business of Merck ... announced an exclusive strategic collaboration and license agreement ... (CAR-T) cancer therapies. This collaboration advances Merck Serono,s ... modulate the immune system,s natural ability to fight ...
(Date:3/30/2015)... and BELLINGHAM, Washington, USA (PRWEB) March 29, 2015 ... in Europe and the United States and plenary talks ... planned for SPIE Optics + Optoelectronics next ... over 700 technical presentations in 17 conferences alongside a ... for optics and photonics , the event will run ...
(Date:3/30/2015)... 30, 2015  Naldemedine, an investigational peripherally acting ... & Co., Ltd., met its primary and secondary ... for the treatment of opioid-induced constipation (OIC) in ... therapy. Study results showed that naldemedine (0.2 mg ... frequency of spontaneous bowel movement (SBM) compared with ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 2Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 3Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy 4Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3
Cached News: